%0 Generic
%T FOLFIRI plus sunitinib versus FOLFIRI alone in advanced chemorefractory esophagogastric cancer patients: A randomized placebo-controlled multicentric AIO phase II trial.
%A Moehler, Markus Hermann
%A Thuss-Patience, Peter C.
%A Schmoll, Hans-Joachim
%A Hegewisch-Becker, Susanna
%A Wilke, Hansjochen
%A Al-Batran, Salah-Eddin
%A Weissinger, Florian
%A Kullmann, Frank
%A Von Weikersthal, Ludwig Fischer
%A Siveke, Jens T.
%A Kanzler, Stephan
%A Schimanski, Carl Christoph
%A Otte, Melanie
%A Schollenberger, Lukas
%A Koenig, Jochem
%A Galle, Peter Robert
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2013
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation